Clinical Trial Update: An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer

View source ↗

Summary

This document reports an observational study evaluating the use of bevacizumab in Chinese patients with metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Peking University | Conditions: Metastatic Colorectal Cancer | Status: UNKNOWN